Jordan Schecter

Person

Livingston, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating high risk multiple myeloma
- Patent number 11,618,787
- Issue date Apr 4, 2023
- Janssen Biotech, Inc.
- Tahamtan Ahmadi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20250000977
- Publication date Jan 2, 2025
- LEGEND BIOTECH USA INC.
- Nitin PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20240358754
- Publication date Oct 31, 2024
- LEGEND BIOTECH USA INC.
- Nitin PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA
- Publication number 20240156962
- Publication date May 16, 2024
- LEGEND BIOTECH USA INC.
- Lida PACAUD
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20240000836
- Publication date Jan 4, 2024
- JANSSEN BIOTECH, INC.
- Jordan Mark SCHECTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating High Risk Multiple Myeloma
- Publication number 20230340145
- Publication date Oct 26, 2023
- JANSSEN BIOTECH, INC.
- Tahamtan Ahmadi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20230277589
- Publication date Sep 7, 2023
- JANSSEN BIOTECH, INC.
- Muhammad AKRAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20230270786
- Publication date Aug 31, 2023
- JANSSEN BIOTECH, INC.
- Xiaohu FAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chai...
- Publication number 20220275101
- Publication date Sep 1, 2022
- JANSSEN BIOTECH, INC.
- Jordan Schecter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA
- Publication number 20220265710
- Publication date Aug 25, 2022
- JANSSEN BIOTECH, INC.
- Jordan Mark SCHECTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...
- Publication number 20220204638
- Publication date Jun 30, 2022
- Xiangyang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...
- Publication number 20200405854
- Publication date Dec 31, 2020
- JANSSEN BIOTECH, INC.
- Xiangyang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...
- Publication number 20200397896
- Publication date Dec 24, 2020
- JANSSEN BIOTECH, INC.
- Xiangyang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...
- Publication number 20200392242
- Publication date Dec 17, 2020
- JANSSEN BIOTECH, INC.
- Xiangyang Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...
- Publication number 20200330594
- Publication date Oct 22, 2020
- JANSSEN BIOTECH, INC.
- Xiangyang Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating High Risk Multiple Myeloma
- Publication number 20190127479
- Publication date May 2, 2019
- Tahamtan Ahmadi
- C07 - ORGANIC CHEMISTRY

Jordan Schecter

Person

Patents Grantslast 30 patents

Methods of treating high risk multiple myeloma

Patents Applicationslast 30 patents

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

Methods of Treating High Risk Multiple Myeloma

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chai...

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...

Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...

Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...

Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...

Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomi...

Methods of Treating High Risk Multiple Myeloma